Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 study of enarodustat (JTZ-951) in hemodialysis patients
jRCT2080221924Phase 1Completed
- Sponsor
- Japan Tobacco
- Start
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of enarodustat in chronic kidney disease (CKD) and anaemia, sponsored by Japan Tobacco. Primary endpoint: Pharmacokinetics of enarodustat. Started Sep 2012; status: completed.
02
Drugs
enarodustat
03
Conditions
chronic kidney disease (CKD)anaemia
Beyond the preview
Go deeper on jRCT2080221924.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221924.